PerkinElmer to acquire antibody and reagent company BioLegend for $5bn
PerkinElmer will make the largest transaction in its history with the acquisition of California’s BioLegend for $5.25bn.
Archives for July 26, 2021
Pfizer and BioNTech continue to add COVID-19 vaccine orders
Pfizer and BioNTech’s deal with the US Government to supply an additional 200 million doses of its COVID-19 vaccine is the latest in the series of new orders.
CPHI NORTH AMERICA 2021
M&A activity vigorous in CDMO arena: CPhI
An expert speaking during the industry event offers insight and perspective on the flurry of CDMO deal-making in recent months, and what might lie ahead.
New eLearning program aimed at enabling faster clinical adoption and improving patient access to ATMPs
A new UK eLearning program is targeted at healthcare and academic professionals to support their learning on advanced therapy medicinal products (ATMPs).
Notes on compliance: Building the USP 71 sterility testing processes that support USP, EP and JP harmonized methods
Paid for and content provided by Thermo Fisher Scientific
Sterility testing is a crucial element of pharmaceutical manufacturing but testing for the absence of objectionable organisms in finished products is just the tip of the iceberg. Find out more